Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Hepatic Glucagon Receptor Signaling Enhances Insulin-Stimulated Glucose Disposal in Rodents.

Kim T, Holleman CL, Nason S, Arble DM, Ottaway N, Chabenne J, Loyd C, Kim JA, Sandoval D, Drucker DJ, DiMarchi R, Perez-Tilve D, Habegger KM.

Diabetes. 2018 Nov;67(11):2157-2166. doi: 10.2337/db18-0068. Epub 2018 Aug 27.

2.

Glucagon Receptor Signaling Regulates Energy Metabolism via Hepatic Farnesoid X Receptor and Fibroblast Growth Factor 21.

Kim T, Nason S, Holleman C, Pepin M, Wilson L, Berryhill TF, Wende AR, Steele C, Young ME, Barnes S, Drucker DJ, Finan B, DiMarchi R, Perez-Tilve D, Tschöp M, Habegger KM.

Diabetes. 2018 Sep;67(9):1773-1782. doi: 10.2337/db17-1502. Epub 2018 Jun 20.

3.

Antiretroviral therapy potentiates high-fat diet induced obesity and glucose intolerance.

Pepin ME, Padgett LE, McDowell RE, Burg AR, Brahma MK, Holleman C, Kim T, Crossman D, Kutsch O, Tse HM, Wende AR, Habegger KM.

Mol Metab. 2018 Jun;12:48-61. doi: 10.1016/j.molmet.2018.04.006. Epub 2018 Apr 20.

4.

LDB1 Regulates Energy Homeostasis During Diet-Induced Obesity.

Loyd C, Liu Y, Kim T, Holleman C, Galloway J, Bethea M, Ediger BN, Swain TA, Tang Y, Stoffers DA, Rowe GC, Young M, Steele C, Habegger KM, Hunter CS.

Endocrinology. 2017 May 1;158(5):1289-1297. doi: 10.1210/en.2016-1791.

5.

Duodenal endoluminal barrier sleeve alters gut microbiota of ZDF rats.

Kim T, Holleman CL, Ptacek T, Morrow CD, Habegger KM.

Int J Obes (Lond). 2017 Mar;41(3):381-389. doi: 10.1038/ijo.2016.224. Epub 2016 Dec 7.

6.

Fibroblast activation protein (FAP) as a novel metabolic target.

Sánchez-Garrido MA, Habegger KM, Clemmensen C, Holleman C, Müller TD, Perez-Tilve D, Li P, Agrawal AS, Finan B, Drucker DJ, Tschöp MH, DiMarchi RD, Kharitonenkov A.

Mol Metab. 2016 Jul 16;5(10):1015-1024. doi: 10.1016/j.molmet.2016.07.003. eCollection 2016 Oct.

7.

DNA methylation regulates neuronal glutamatergic synaptic scaling.

Meadows JP, Guzman-Karlsson MC, Phillips S, Holleman C, Posey JL, Day JJ, Hablitz JJ, Sweatt JD.

Sci Signal. 2015 Jun 23;8(382):ra61. doi: 10.1126/scisignal.aab0715.

8.

Can sugammadex save a patient in a simulated 'cannot intubate, cannot ventilate' situation?

Bisschops MM, Holleman C, Huitink JM.

Anaesthesia. 2010 Sep;65(9):936-41. doi: 10.1111/j.1365-2044.2010.06455.x.

9.

Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis.

Hudson MP, O'Connor CM, Gattis WA, Tasissa G, Hasselblad V, Holleman CM, Gaulden LH, Sedor F, Ohman EM.

Am Heart J. 2004 Mar;147(3):546-52.

PMID:
14999208
10.

Cardiac troponin T levels in umbilical cord blood.

Shelton SD, Fouse BL, Holleman CM, Sedor FA, Herbert WN.

Am J Obstet Gynecol. 1999 Nov;181(5 Pt 1):1259-62.

PMID:
10561656
11.

Reflotron cholesterol measurement evaluated as a screening technique.

Sedor FA, Holleman CM, Heyden S, Schneider KA.

Clin Chem. 1988 Dec;34(12):2542-5.

12.

Reduction of severe hypoglycemic events in type I (insulin dependent) diabetic patients using continuous subcutaneous insulin infusion.

Eichner HL, Selam JL, Holleman CB, Worcester BR, Turner DS, Charles MA.

Diabetes Res. 1988 Aug;8(4):189-93.

PMID:
3148381
13.

Evaluation of the IL 482 CO-Oximeter.

Sedor FA, Holleman CM.

Clin Chem. 1987 Oct;33(10):1942-3. No abstract available.

PMID:
3665064
14.
15.
16.

Investigation of captopril for methodological interferences in continuous-flow (SMAC) profiles.

Sedor FA, Holleman CM.

Clin Chem. 1981 Jan;27(1):208-9. No abstract available.

17.

Classification of bronchial lymphocytes from nonsmokers and smokers.

Warr GA, Martin RR, Holleman CL, Criswell BS.

Am Rev Respir Dis. 1976 Jan;113(1):96-100.

PMID:
1082283
18.

Rapid method for protein quantitation by electroimmunodiffusion.

Gill CW, Fischer CL, Holleman CL.

Clin Chem. 1971 Jun;17(6):501-4. No abstract available.

Supplemental Content

Loading ...
Support Center